Paper Details
- Home
- Paper Details
Original Abstract of the Article :
A 53-year-old man who has stage 4 non-small cell lung carcinoma and treated with Dabrafenib-Trametinib combination chemotherapy; presented with decreased bilateral visual acuity. We checked out slit lamp examination, fundoscopy, optical coherence tomography and fundus fluorescein angiography. In sli...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097848/
データ提供:米国国立医学図書館(NLM)
Ocular Side Effects of Trametinib and Dabrafenib: A Case Report
This case report examines the ocular side effects associated with the use of a combination chemotherapy regimen, dabrafenib-trametinib, in a patient with stage 4 non-small cell lung carcinoma. The report describes a 53-year-old man who developed bilateral visual acuity loss after receiving this treatment. The researchers conducted a thorough ophthalmological examination, including slit lamp biomicroscopy, fundoscopy, optical coherence tomography, and fundus fluorescein angiography. They identified several ocular abnormalities, including posterior synechiae, granulomatous keratic precipitates, cystoid macular edema, and subretinal fluid accumulation. The treatment regimen was discontinued, and the patient received systemic and topical corticosteroids. The patient's visual acuity improved, and the ocular abnormalities resolved with treatment.
Ocular Side Effects of Dabrafenib-Trametinib: A Reminder of Potential Complications
This case report highlights the potential for ocular side effects associated with the use of dabrafenib-trametinib chemotherapy. The patient's experience underscores the importance of vigilant monitoring for ocular complications during treatment with this regimen. It's like navigating a desert landscape, where unexpected obstacles can arise, requiring careful observation and appropriate interventions.
What Does This Mean for You?
This case report emphasizes the importance of discussing potential side effects with your doctor, especially when undergoing chemotherapy treatment. It's crucial to report any changes in your vision or other health concerns immediately. Regular monitoring and communication with your healthcare team are essential for managing potential complications and ensuring the best possible outcomes. Just as a camel navigates a desert, seeking shade and water when needed, it's vital to seek medical attention when you experience any health concerns.
Dr.Camel's Conclusion
This case report serves as a reminder that even with advancements in cancer treatment, there can be potential side effects. It's a testament to the importance of close monitoring and proactive communication with healthcare professionals. Just as a camel carefully observes its surroundings, we must be vigilant in our health journeys, seeking guidance and support when needed.
Date :
- Date Completed n.d.
- Date Revised 2023-04-15
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.